All In Biotech

Free tool

FAERS Monitor: Triptodur Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208956 or its brand name (Triptodur Kit, Triptorelin Pamoate). Reports on generic versions are filed under their own applications.

Reports

3,354

Serious

2,156

64% of reports

Hospitalization

831

Death reported

198

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use289
  • needle issue199
  • disease progression133
  • product dose omission issue125
  • drug ineffective118
  • headache114
  • injection site pain104
  • weight increased104
  • ovarian hyperstimulation syndrome101
  • vaginal haemorrhage95
  • syringe issue90
  • asthenia88
  • fatigue85
  • pyrexia82
  • vomiting81

Reports by year received

View as table
YearReports
20044
200510
20063
200713
200814
200910
201024
201119
201219
201310
201429
201533
201619
201751
2018180
2019459
2020378
2021420
2022309
2023342
2024331
2025439
2026238

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,805 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ovarian hyperstimulation syndromeSignal101284.0233.326,983
needle issueSignal19943.237.78,108
syringe issueSignal9032.426.42,697
vaginal haemorrhageSignal9513.811.31,111
disease progressionSignal1337.16.0688
weight increasedSignal1042.92.4130
product dose omission issueSignal1252.72.2130
injection site painSignal1042.11.862
off label useSignal2892.11.9166
pyrexia821.51.213
asthenia881.51.213
headache1141.11.02
vomiting811.10.90
fatigue850.70.612
drug ineffective1180.60.543

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.